90 related articles for article (PubMed ID: 12667306)
1. The influence of isorel on the advanced colorectal cancer.
Cazacu M; Oniu T; Lungoci C; Mihailov A; Cipak A; Klinger R; Weiss T; Zarkovic N
Cancer Biother Radiopharm; 2003 Feb; 18(1):27-34. PubMed ID: 12667306
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings.
Sunjic SB; Gasparovic AC; Vukovic T; Weiss T; Weiss ES; Soldo I; Djakovic N; Zarkovic T; Zarkovic N
Coll Antropol; 2015 Sep; 39(3):701-8. PubMed ID: 26898069
[TBL] [Abstract][Full Text] [Related]
3. An overview on anticancer activities of the Viscum album extract Isorel.
Zarkovic N; Vukovic T; Loncaric I; Miletic M; Zarkovic K; Borovic S; Cipak A; Sabolovic S; Konitzer M; Mang S
Cancer Biother Radiopharm; 2001 Feb; 16(1):55-62. PubMed ID: 11279798
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
5. Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients.
Enesel MB; Acalovschi I; Grosu V; Sbarcea A; Rusu C; Dobre A; Weiss T; Zarkovic N
Anticancer Res; 2005; 25(6C):4583-90. PubMed ID: 16334146
[TBL] [Abstract][Full Text] [Related]
6. [Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
Kast A; Hauser SP
Schweiz Rundsch Med Prax; 1990 Mar; 79(11):332-4. PubMed ID: 2315589
[TBL] [Abstract][Full Text] [Related]
7. Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel.
Jurin M; Zarković N; Hrzenjak M; Ilić Z
Oncology; 1993; 50(6):393-8. PubMed ID: 8233280
[TBL] [Abstract][Full Text] [Related]
8. Systematic evaluation of the clinical effects of supportive mistletoe treatment within chemo- and/or radiotherapy protocols and long-term mistletoe application in nonmetastatic colorectal carcinoma: multicenter, controlled, observational cohort study.
Friedel WE; Matthes H; Bock PR; Zänker KS
J Soc Integr Oncol; 2009; 7(4):137-45. PubMed ID: 19883529
[TBL] [Abstract][Full Text] [Related]
9. Viscum album L. preparation Isorel modifies the immune response in normal and in tumour-bearing mice.
Jurin M; Zarkovic N; Borovic S; Kissel D
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S27-31. PubMed ID: 9179364
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
[TBL] [Abstract][Full Text] [Related]
11. The Viscum album preparation Isorel inhibits the growth of melanoma B16F10 by influencing the tumour-host relationship.
Zarkovic N; Zarkovic K; Grainca S; Kissel D; Jurin M
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S17-22. PubMed ID: 9179362
[TBL] [Abstract][Full Text] [Related]
12. [Fermented wheat germ extract in the supportive therapy of colorectal cancer].
Farkas E
Orv Hetil; 2005 Sep; 146(37):1925-31. PubMed ID: 16255377
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
[TBL] [Abstract][Full Text] [Related]
14. Mistletoe extract reduces the surgical suppression of natural killer cell activity in cancer patients. a randomized phase III trial.
Schink M; Tröger W; Dabidian A; Goyert A; Scheuerecker H; Meyer J; Fischer IU; Glaser F
Forsch Komplementmed; 2007 Feb; 14(1):9-17. PubMed ID: 17341882
[TBL] [Abstract][Full Text] [Related]
15. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial.
Piao BK; Wang YX; Xie GR; Mansmann U; Matthes H; Beuth J; Lin HS
Anticancer Res; 2004; 24(1):303-9. PubMed ID: 15015612
[TBL] [Abstract][Full Text] [Related]
16. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a novel herbal agent MB-6 as a potential adjunct to 5-fluoracil-based chemotherapy in colorectal cancer.
Chen WT; Yang TS; Chen HC; Chen HH; Chiang HC; Lin TC; Yeh CH; Ke TW; Chen JS; Hsiao KH; Kuo ML
Nutr Res; 2014 Jul; 34(7):585-94. PubMed ID: 25150117
[TBL] [Abstract][Full Text] [Related]
18. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
[TBL] [Abstract][Full Text] [Related]
19. [Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma].
Bokemeyer C; Hartmann JT; Kanz L
Praxis (Bern 1994); 1997 Sep; 86(39):1510-6. PubMed ID: 9411671
[TBL] [Abstract][Full Text] [Related]
20. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]